Grow home monitoring
- Home monitoring – Asthma registry app. A remote monitoring solution for asthma biologics patients is currently being commissioned that will collect standardised outcome data and feed directly into the UK Severe Asthma Registry. To be launched soon!
Homecare and self-administration
Increasing the use of homecare services for asthma biologic treatment can increase the capacity for centres to see new patients and, improve patient access to treatment by reducing the need for patients to travel.
An introduction to asthma biologics homecare has been developed by the Oxford AHSN. Learn more about homecare.
To support centres and systems to understand variation in homecare utilisation for asthma biologics, a homecare dashboard has been developed. This can be made available through local AHSN leads.
Other relevant homecare resources:
- Paper A – BTS mepolizumab poster The poster recently presented at the British Thoracic Society Conference give reassurance that that not only do symptoms not deteriorate in patients that transition to homecare, but there is also a significant improvement in ACQ6. d’Ancona G, Stewart-Kelcher N, Bains S, et al. P105 Does asthma control change when patients transition to home administration of mepolizumab? Thorax 2021;76:A144-A145.
- Paper B – BTS benralizumab poster The poster recently presented at the British Thoracic Society Conference give reassurance that that not only do symptoms not deteriorate in patients that transition to homecare, but there is also a significant improvement in ACQ6. d’Ancona G, Bains S, Stewart-Kelcher N, et al P104 Does asthma control change following transition to home benralizumab administration? Thorax 2021;76:A144.
- Transfer timescale to patient self-administration for sub-cutaneous biologic therapy This sliding scale assessment guide and published paper support clinicians when deciding which patients could be considered for homecare provision.